Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PRECISE-HA appears to refer to a specific formulation or brand of hyaluronic acid (HA) product, likely used as a dermal filler or for other medical/cosmetic applications. Hyaluronic acid is an anionic, nonsulfated glycosaminoglycan naturally found in connective, epithelial, and neural tissues. It is widely used for its viscoelasticity, moisturizing properties, and ability to support tissue regeneration and wound healing. In clinical practice, HA fillers are commonly injected for aesthetic purposes such as reducing wrinkles and restoring facial volume[4]. The "PRECISE" designation may indicate a particular cross-linking technology or proprietary formulation designed for enhanced precision in application; however, no direct regulatory listing or detailed public information about "PRECISE-HA" specifically was identified in the available sources.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PRECISE-HA.